🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Institut Jules Bordet
Start Date
1999-07
Trial ID
NCT00004884
Treatments Being Tested
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024
In this randomized trial, we attempt to further define optimal palliative c...
Status
Completed
Location
Tennessee Oncology, PLLC
Start Date
2001-08
Trial ID
NCT00193323
Treatments Being Tested
Urothelial carcinoma (UC) is the ninth most common cancer type worldwide. W...
Status
Active Not Recruiting
Location
Highlands Oncology Group - Springdale /ID# 270290
Start Date
2025-01-20
Trial ID
NCT06632951
Treatments Being Tested
Anti-angiogenesis Tyrosine kinase inhibitors (TKIs) have been proved to sho...
Status
Completed
Location
Musculoskeletal Tumor Center of Peking University People's Hospital
Start Date
2015-06-01
Trial ID
NCT03491371
Treatments Being Tested
This phase I/II trial tests the side effects and best dose of abemaciclib w...
Status
Recruiting
Location
UT MD Anderson Cancer Center
Start Date
2026-03-18
Trial ID
NCT06498648
Treatments Being Tested
Lung cancer is the leading cause of cancer-related deaths worldwide. Accord...
Status
Recruiting
Location
Anhui cancer hospital
Start Date
2025-10-30
Trial ID
NCT07330596
Treatments Being Tested
Lung cancer is one of the most common malignancies worldwide and the leadin...
Status
Unknown
Location
Hospital Virgen de los Lirios
Start Date
2007-10
Trial ID
NCT00905983
Treatments Being Tested
To compare outcomes between the CRS group and the control group in patients...
Status
Recruiting
Location
National Cancer Center, Korea
Start Date
2025-09-10
Trial ID
NCT07171528
Treatments Being Tested